Bingkun Wang

1PUBLICATIONS
12CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 12, 2025
Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma.

Hongkai Zhuang, Chenwei Tang, Wentao Wang

Pageof 1

Frequent Collaborators

1 joint publications

Hongkai Zhuang

1 joint publications

Chenwei Tang

1 joint publications

Wentao Wang

1 joint publications

Bo Chen

1 joint publications

Yonglin Hua

1 joint publications

Xiaowu Ma

1 joint publications

Qingbin Wang

1 joint publications

Wenliang Tan

1 joint publications

Lei Yang

1 joint publications

Zhiqin Xie

Frequent Collaborators

1 joint publications

Hongkai Zhuang

1 joint publications

Chenwei Tang

1 joint publications

Wentao Wang

1 joint publications

Bo Chen

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

352
See more related videos

Top Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

352
See more related videos